Quantum Cyber N V 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Quantum Cyber N V 's ROA in the second quarter of 2026?
Quantum Cyber N V recorded a cumulative net loss of $-36 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -263.66%.

However, within the Healthcare sector 888 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4569, from total ROA ranking in the first quarter of 2026 at 5286.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Total Assets Change	55.5 %	-20.72 %	-46.47 %	-61.37 %	-43.68 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-36	-30	-30	-20	-25
Return On Assets (TTM)	-263.66 %	-259.67 %	-249.57 %	-134.66 %	-132.14 %
MYNZ's Total Ranking	# 4569	# 5286	#	# 4632	# 4720
Total Assets (TTM) in million	24	8	13	10	15
Seq. Total Assets Change	206.01 %	-41.34 %	34.21 %	-35.45 %	56.02 %
Seq. Net Income Change	-	-	-	-	-

MYNZ's 5 Years Annual ROA >> Back to MYNZ Management Effectiveness >> Compare MYNZ ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 424
Sector	# 889
Overall	# 4514

Return On Assets Statistics
High	Average	Low
-119.48 %	-199.42 %	-327.65 %
(Dec 31 2022)		(Mar 31 2026)

Financial Statements
Quantum Cyber N V 's Assets	$ 24 million	MYNZ's Balance sheet
Quantum Cyber N V 's Income	$ -11 million	Quarterly MYNZ's Income Statement
MYNZ's Income by Division		See MYNZ's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-9.71 %	-43.76 %	-34.25 %	91.01 %	-
Total Assets in million	12	14	25	37	20
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-16	-22	-26	-26	-12
Annual Return On Assets	-129.88 %	-156.63 %	-106.98 %	-70.59 %	-59.73 %

MYNZ's 5 Years Annual ROA >> Back to MYNZ Management Effectiveness >> Compare MYNZ ROA to its Competitors

More Return On Assets Ratios
MYNZ's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MYNZ's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MYNZ's Competitors
Subscribers only: Roa for Quantum Cyber N V 's Suppliers
Subscribers only: Return On Assets for MYNZ's Customers

You may also want to know
MYNZ's Roi	MYNZ's Inventory Turnover Ratio	MYNZ's Growth Rates	MYNZ's Dividend Comparisons
	MYNZ's Profitability Ratios	MYNZ's Asset Turnover Ratio	MYNZ's Dividend Growth
MYNZ's Roe	MYNZ's Valuation Ratios	MYNZ's Financial Strength Ratios	MYNZ's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:41:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.